Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Cellular and molecular basis of Venous insufficiency.

Pocock ES, Alsaigh T, Mazor R, Schmid-Schönbein GW.

Vasc Cell. 2014 Dec 12;6(1):24. doi: 10.1186/s13221-014-0024-5. eCollection 2014.

2.

The role of angiogenesis in the pathology of multiple sclerosis.

Lengfeld J, Cutforth T, Agalliu D.

Vasc Cell. 2014 Nov 28;6(1):23. doi: 10.1186/s13221-014-0023-6. eCollection 2014.

3.

Previously differentiated medial vascular smooth muscle cells contribute to neointima formation following vascular injury.

Herring BP, Hoggatt AM, Burlak C, Offermanns S.

Vasc Cell. 2014 Oct 1;6:21. doi: 10.1186/2045-824X-6-21. eCollection 2014.

4.

Lysosomal drug sequestration as a mechanism of drug resistance in vascular sarcoma cells marked by high CSF-1R expression.

Gorden BH, Saha J, Khammanivong A, Schwartz GK, Dickerson EB.

Vasc Cell. 2014 Oct 1;6:20. doi: 10.1186/2045-824X-6-20. eCollection 2014.

5.

Ageing and microvasculature.

Scioli MG, Bielli A, Arcuri G, Ferlosio A, Orlandi A.

Vasc Cell. 2014 Sep 16;6:19. doi: 10.1186/2045-824X-6-19. eCollection 2014. Review.

6.

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage.

Yamamoto Y, Matsui J, Matsushima T, Obaishi H, Miyazaki K, Nakamura K, Tohyama O, Semba T, Yamaguchi A, Hoshi SS, Mimura F, Haneda T, Fukuda Y, Kamata JI, Takahashi K, Matsukura M, Wakabayashi T, Asada M, Nomoto KI, Watanabe T, Dezso Z, Yoshimatsu K, Funahashi Y, Tsuruoka A.

Vasc Cell. 2014 Sep 6;6:18. doi: 10.1186/2045-824X-6-18. eCollection 2014.

7.

Evaluation of side effects of radiofrequency capacitive hyperthermia with magnetite on the blood vessel walls of tumor metastatic lesion surrounding the abdominal large vessels: an agar phantom study.

Kawai N, Kobayashi D, Yasui T, Umemoto Y, Mizuno K, Okada A, Tozawa K, Kobayashi T, Kohri K.

Vasc Cell. 2014 Jul 15;6:15. doi: 10.1186/2045-824X-6-15. eCollection 2014.

8.

Limitations of the dorsal skinfold window chamber model in evaluating anti-angiogenic therapy during early phase of angiogenesis.

Biel NM, Lee JA, Sorg BS, Siemann DW.

Vasc Cell. 2014 Aug 4;6:17. doi: 10.1186/2045-824X-6-17. eCollection 2014.

9.

VEGFR-1 blockade disrupts peri-implantation decidual angiogenesis and macrophage recruitment.

Douglas NC, Zimmermann RC, Tan QK, Sullivan-Pyke CS, Sauer MV, Kitajewski JK, Shawber CJ.

Vasc Cell. 2014 Aug 1;6:16. doi: 10.1186/2045-824X-6-16. eCollection 2014.

10.

In vitro pre-vascularisation of tissue-engineered constructs A co-culture perspective.

Baldwin J, Antille M, Bonda U, De-Juan-Pardo EM, Khosrotehrani K, Ivanovski S, Petcu EB, Hutmacher DW.

Vasc Cell. 2014 Jun 21;6:13. doi: 10.1186/2045-824X-6-13. eCollection 2014. Review.

11.

Flow-regulated lymphatic vasculature development and signaling.

Wang Y, Simons M.

Vasc Cell. 2014 Jul 9;6:14. doi: 10.1186/2045-824X-6-14. eCollection 2014. Review.

12.

Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cells.

Fanelli R, Schembri L, Piarulli U, Pinoli M, Rasini E, Paolillo M, Galiazzo MC, Cosentino M, Marino F.

Vasc Cell. 2014 May 21;6:11. doi: 10.1186/2045-824X-6-11. eCollection 2014.

13.

Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.

Chinchar E, Makey KL, Gibson J, Chen F, Cole SA, Megason GC, Vijayakumar S, Miele L, Gu JW.

Vasc Cell. 2014 Jun 1;6:12. doi: 10.1186/2045-824X-6-12. eCollection 2014.

14.

Angiogenic properties of dehydrated human amnion/chorion allografts: therapeutic potential for soft tissue repair and regeneration.

Koob TJ, Lim JJ, Massee M, Zabek N, Rennert R, Gurtner G, Li WW.

Vasc Cell. 2014 May 1;6:10. doi: 10.1186/2045-824X-6-10. eCollection 2014.

15.

The role of RNA interference in the developmental separation of blood and lymphatic vasculature.

Gauvrit S, Philippe J, Lesage M, Tjwa M, Godin I, Germain S.

Vasc Cell. 2014 Apr 1;6(1):9. doi: 10.1186/2045-824X-6-9.

16.

The discovery of angiogenic growth factors: the contribution of Italian scientists.

Ribatti D.

Vasc Cell. 2014 Apr 1;6(1):8. doi: 10.1186/2045-824X-6-8.

17.

Development of immortalized mouse aortic endothelial cell lines.

Ni CW, Kumar S, Ankeny CJ, Jo H.

Vasc Cell. 2014 Apr 1;6(1):7. doi: 10.1186/2045-824X-6-7.

18.

Embryonic rat vascular smooth muscle cells revisited - a model for neonatal, neointimal SMC or differentiated vascular stem cells?

Kennedy E, Hakimjavadi R, Greene C, Mooney CJ, Fitzpatrick E, Collins LE, Loscher CE, Guha S, Morrow D, Redmond EM, Cahill PA.

Vasc Cell. 2014 Mar 15;6(1):6. doi: 10.1186/2045-824X-6-6.

19.

Macrophages in solid organ transplantation.

Jiang X, Tian W, Sung YK, Qian J, Nicolls MR.

Vasc Cell. 2014 Mar 11;6(1):5. doi: 10.1186/2045-824X-6-5.

20.

Effect of the vascular endothelial growth factor expression level on angiopoietin-2-mediated nasopharyngeal carcinoma growth.

Chen HH, Weng BQ, Cheng KJ, Liu HY, Wang SQ, Lu YY.

Vasc Cell. 2014 Mar 1;6(1):4. doi: 10.1186/2045-824X-6-4.

Supplemental Content

Loading ...
Support Center